Most bought healthcare stocks in Q4 2017
See which Healthcare stocks institutional investors increased the most in Q4 2017, measured as net growth in reported share positions from Q3 2017 into Q4 2017. Notable additions at the top of this list include TEVA PHARMACEUTICAL-SP ADR (TEVA), IQVIA HOLDINGS INC (IQV), HOLOGIC INC (HOLX), AGILENT TECHNOLOGIES INC (A). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 17,038,234 | $352.75M | 3 | 0 | 2 | 0 | 7 |
| IQV | IQVIA HOLDINGS INC | 10,874,245 | $1.06B | 3 | 0 | 0 | 0 | 3 |
| HOLX | HOLOGIC INC | 6,175,467 | $317.96M | 0 | 2 | 1 | 1 | 3 |
| A | AGILENT TECHNOLOGIES INC | 5,097,762 | $356.46M | 1 | 1 | 1 | 0 | 4 |
| XRAY | DENTSPLY SIRONA INC | 3,728,439 | $279.91M | 1 | 1 | 2 | 0 | 4 |
| BMY | BRISTOL-MYERS SQUIBB CO | 3,598,861 | $114.12M | 0 | 4 | 3 | 0 | 11 |
| GILD | GILEAD SCIENCES INC | 3,078,717 | -$172.80M | 0 | 7 | 2 | 2 | 10 |
| COR | CENCORA INC | 2,957,376 | $326.07M | 0 | 3 | 0 | 0 | 3 |
| ZTS | ZOETIS INC | 2,950,595 | $264.76M | 1 | 0 | 2 | 1 | 3 |
| BDX | BECTON DICKINSON AND CO | 1,666,194 | $474.16M | 0 | 3 | 6 | 0 | 10 |
| CVS | CVS HEALTH CORP | 1,661,987 | -$31.99M | 1 | 4 | 3 | 2 | 8 |
| CAH | CARDINAL HEALTH INC | 1,650,841 | $37.97M | 1 | 4 | 2 | 1 | 7 |
| VRTX | VERTEX PHARMACEUTICALS INC | 1,479,897 | $218.79M | 0 | 1 | 0 | 0 | 1 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 1,371,094 | $152.96M | 0 | 2 | 0 | 0 | 2 |
| ISRG | INTUITIVE SURGICAL INC | 1,296,352 | $83.04M | 0 | 3 | 0 | 0 | 3 |
| CORT | CORCEPT THERAPEUTICS INC | 1,284,745 | $18.65M | 0 | 1 | 0 | 0 | 1 |
| MCRB | SERES THERAPEUTICS INC | 1,030,879 | $1.57M | 0 | 2 | 0 | 0 | 2 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,002,671 | $17.17M | 0 | 1 | 0 | 0 | 1 |
| MD | PEDIATRIX MEDICAL GROUP INC | 962,030 | $51.41M | 1 | 0 | 0 | 0 | 1 |
| VCYT | VERACYTE INC | 908,467 | $3.60M | 0 | 1 | 1 | 0 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | 839,818 | $8.15M | 1 | 0 | 0 | 0 | 1 |
| MOH | MOLINA HEALTHCARE INC | 816,966 | $89.19M | 1 | 1 | 1 | 0 | 3 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | 801,750 | $29.27M | 0 | 1 | 1 | 0 | 2 |
| NKTR | NEKTAR THERAPEUTICS | 759,748 | $87.03M | 1 | 1 | 0 | 0 | 2 |
| HSIC | HENRY SCHEIN INC | 687,060 | $47.91M | 1 | 1 | 0 | 0 | 2 |
| INCY | INCYTE CORP | 679,456 | $59.35M | 1 | 1 | 1 | 1 | 3 |
| AMGN | AMGEN INC | 548,700 | $41.14M | 0 | 5 | 4 | 1 | 10 |
| CPRX | CATALYST PHARMACEUTICALS INC | 532,500 | $2.89M | 0 | 1 | 0 | 0 | 1 |
| PODD | INSULET CORP | 506,800 | $37.12M | 0 | 1 | 0 | 0 | 1 |
| VKTX | VIKING THERAPEUTICS INC | 500,700 | $2.90M | 0 | 1 | 0 | 0 | 1 |
| REGN | REGENERON PHARMACEUTICALS | 469,702 | $69.69M | 0 | 3 | 0 | 2 | 3 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 434,701 | $61.17M | 1 | 1 | 0 | 0 | 2 |
| EBS | EMERGENT BIOSOLUTIONS INC | 432,300 | $27.03M | 0 | 1 | 0 | 0 | 1 |
| EDIT | EDITAS MEDICINE INC | 424,975 | $29.17M | 0 | 1 | 0 | 0 | 2 |
| AKBA | AKEBIA THERAPEUTICS INC | 400,300 | -$868.00K | 0 | 1 | 0 | 0 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 387,241 | $30.05M | 1 | 0 | 0 | 0 | 1 |
| WAT | WATERS CORP | 361,711 | $171.47M | 0 | 3 | 1 | 0 | 4 |
| HCA | HCA HEALTHCARE INC | 356,677 | $56.92M | 0 | 1 | 1 | 0 | 2 |
| ARAY | ACCURAY INC | 347,500 | $2.76M | 0 | 1 | 0 | 0 | 1 |
| CERS | CERUS CORP | 320,957 | $3.19M | 0 | 1 | 0 | 1 | 1 |
| SNN | SMITH & NEPHEW PLC -SPON ADR | 299,300 | $10.43M | 0 | 1 | 0 | 0 | 1 |
| LLY | ELI LILLY & CO | 293,220 | -$5.57M | 0 | 4 | 2 | 0 | 6 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 293,092 | $684.00K | 1 | 1 | 0 | 0 | 2 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 283,688 | $15.29M | 0 | 1 | 0 | 0 | 1 |
| LNTH | LANTHEUS HOLDINGS INC | 276,300 | $7.31M | 0 | 1 | 0 | 0 | 1 |
| DGX | QUEST DIAGNOSTICS INC | 260,392 | $29.78M | 0 | 2 | 0 | 0 | 2 |
| AXGN | AXOGEN INC | 255,400 | $10.83M | 0 | 1 | 0 | 0 | 1 |
| NVS | NOVARTIS AG-SPONSORED ADR | 247,239 | -$85.36M | 1 | 7 | 3 | 0 | 12 |
| ABUS | ARBUTUS BIOPHARMA CORP | 241,963 | $1.04M | 0 | 1 | 0 | 0 | 1 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | 237,200 | $9.34M | 0 | 2 | 0 | 0 | 2 |
Frequently asked questions about Most bought healthcare stocks in Q4 2017
What are the most bought Healthcare stocks in Q4 2017?
The most bought healthcare stocks in Q4 2017 are those with the largest increase in reported share counts across institutional investors compared to Q3 2017, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q4 2017?
Among filers in this sector, net additions were largest in companies such as TEVA PHARMACEUTICAL-SP ADR (TEVA), IQVIA HOLDINGS INC (IQV), HOLOGIC INC (HOLX), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2017).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.